BSEM NASDAQ
BioStem Technologies, Inc.
1W: -34.1%
1M: -22.9%
3M: -25.4%
YTD: -30.4%
1Y: -45.3%
3Y: +11.4%
5Y: +110.0%
$2.73
-0.34 (-11.07%)
Weekly Expected Move ±16.0%
$2
$2
$3
$3
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$47M
-84.3% ▼
5Y CAGR: +79.9%
Gross Profit
$44M
-84.6% ▼
5Y CAGR: +104.0%
Operating Income
-$689K
-102.2% ▼
Net Income
-$7M
-120.6% ▼
EPS (Diluted)
$-0.39
-126.5% ▼
EBITDA
-$470K
-101.5% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $4M | $7M | $17M | $302M | $47M |
| YoY Growth | +72.1% | +58.4% | +142.7% | +1708.9% | -84.3% |
| Cost of Revenue | $1M | $882K | $1M | $14M | $3M |
| Gross Profit | $3M | $6M | $15M | $288M | $44M |
| Gross Margin | 66.0% | 87.2% | 92.4% | 95.4% | 93.1% |
| R&D Expenses | $120K | $123K | $342K | $2M | $7M |
| SG&A Expenses | $4M | $10M | $23M | $255M | $38M |
| Operating Expenses | $4M | $11M | $23M | $257M | $45M |
| Operating Income | -$2M | -$5M | -$8M | $31M | -$689K |
| Operating Margin | -37.0% | -68.1% | -46.6% | 10.3% | -1.5% |
| Interest Expense | $526K | $468K | $700K | $587K | $0 |
| Income Before Tax | -$1M | -$7M | -$8M | $31M | -$390K |
| Tax Expense | $0 | $0 | $0 | -$1M | $6M |
| Net Income | -$1M | -$7M | -$8M | $32M | -$7M |
| Net Margin | -33.3% | -102.9% | -50.8% | 10.6% | -13.9% |
| EPS (Diluted) | $-0.12 | $-0.62 | $-0.62 | $1.47 | $-0.39 |
| EBITDA | -$602K | -$7M | -$8M | $31M | -$470K |
| Shares Outstanding | 12M | 11M | 14M | 22M | 17M |